Nevirapine (Viramune): European warning.
An official European warning urges heightened precautions especially during the first 8 weeks that this drug is used.
D005060:Europe; D019829:Nevirapine / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine